TY  - GEN
AU  - Piao,Chun Shu
AU  - Kim,Jung-Bin
AU  - Han,Pyung-Lim
AU  - Lee,Ja-Kyeong
TI  - Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult
SN  - 0360-4012
PY  - 2003///0908
KW  - Animals
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - therapeutic use
KW  - Astrocytes
KW  - drug effects
KW  - Blotting, Western
KW  - methods
KW  - Brain
KW  - Brain Infarction
KW  - metabolism
KW  - Cyclooxygenase 2
KW  - Cytokines
KW  - genetics
KW  - Disease Models, Animal
KW  - Gene Expression Regulation
KW  - Imidazoles
KW  - Immunohistochemistry
KW  - Infarction, Middle Cerebral Artery
KW  - physiopathology
KW  - Isoenzymes
KW  - Lectins
KW  - Male
KW  - Microglia
KW  - Mitogen-Activated Protein Kinase 14
KW  - Mitogen-Activated Protein Kinases
KW  - antagonists & inhibitors
KW  - Neurologic Examination
KW  - Nitric Oxide Synthase
KW  - Nitric Oxide Synthase Type II
KW  - Prostaglandin-Endoperoxide Synthases
KW  - Pyridines
KW  - RNA, Messenger
KW  - biosynthesis
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Tetrazolium Salts
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jnr.10671
ER  -